Full text is available at the source.
Abstract
An estimated 1 in 800 individuals in the United States have Hypermobile Ehlers-Danlos Syndrome (hEDS).
- Patients with hEDS were nearly three times more likely to develop Long COVID compared to matched controls despite similar rates of COVID-19 infection.
- The increased risk of Long COVID was particularly significant among hEDS patients with overlapping conditions such as autonomic dysfunction, immune dysregulation, and chronic fatigue.
- hEDS patients demonstrated higher odds of additional risk factors for severe or prolonged illness, including chronic lung issues, autoimmune conditions, depression, and cerebrovascular disease.
- A subgroup of patients received their hEDS diagnosis only after being diagnosed with COVID-19 or Long COVID, showing a high prevalence of comorbid conditions like POTS and MCAS.
- Findings indicate that hEDS is more prevalent than previously recognized and highlight the need for improved screening and integrated care for affected individuals.
Simplified